Compare DCTH & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCTH | SRTA |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.5M | 425.3M |
| IPO Year | 2015 | N/A |
| Metric | DCTH | SRTA |
|---|---|---|
| Price | $11.11 | $5.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $22.00 | $7.81 |
| AVG Volume (30 Days) | 378.1K | ★ 857.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.53 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.54 | $39.27 |
| Revenue Next Year | $33.15 | $8.52 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.12 | $3.85 |
| 52 Week High | $18.23 | $6.02 |
| Indicator | DCTH | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 56.42 |
| Support Level | $10.17 | $5.21 |
| Resistance Level | $11.24 | $5.31 |
| Average True Range (ATR) | 0.56 | 0.29 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 46.85 | 43.63 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.